Topics:

Drug Benefit Trends

Drug Benefit Trends

Trends in HIV Care, Part 2: Antiretrovirals in the Pipeline, HIV/Hepatitis C Virus Coinfection, and Pharmacokinetics of Treatment Adherence—A Roundtable Discussion

Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis.

Children with sickle cell disease (SCD) were shown to have annual medical costs of $9369 (Medicaid) and $13,469 (private insurance), which is significantly higher than that for children without SCD, according to a study led by Djesika D. Amendah, PhD, an economist at the CDC.1 SCD in children resulted in total medical costs of at least $335 million per year in the United States in 2005.

The effect of payment delays on the normal functioning of community pharmacy operations has been documented. We undertook a study to evaluate and compare pharmacists’ perception regarding reimbursement rates and processing time for prescription drug claims processed for Medicare Part D, Medicaid, and commercial managed care plans.

Common behaviors of patients taking prescription drugs, such as forgetfulness and procrastination, may result in wasteful spending of $163 billion annually, according to the recently released 2009 Drug Trend Report from Express Scripts.

The US Department of Veterans Affairs (VA) invested in health information technology (IT) and produced a net savings of $3.09 billion, according to results of a new study conducted by the Center for Information Technology Leadership (CITL).1

Little progress has been made in eliminating health care–associated infections (HAIs), according to the 2009 National Healthcare Quality Report and the National Healthcare Disparities Report recently issued by the Department of Health and Human Services’ (HHS) Agency for Healthcare Research and Quality (AHRQ).1

Pages

Subscribe to
Please Wait 20 seconds or click here to close